| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/04/1997 | US5607946 Quinolone derivatives as dopamine D4 ligands |
| 03/04/1997 | US5607945 Use as antipsychotics, analgesics and depot pharmaceuticals |
| 03/04/1997 | US5607944 Bicyclic heterocyclic compounds, pharmaceutical preparations containing these compounds and processes for their preparations |
| 03/04/1997 | US5607943 Cardioprotective, cerebroprotective, antiinflammatory agents |
| 03/04/1997 | US5607942 Bactericides |
| 03/04/1997 | US5607940 Drug delivery for narcotic analgesics |
| 03/04/1997 | US5607938 Medicament for treating or preventing cerebrovascular infarction |
| 03/04/1997 | US5607937 Piperazides of substituted phenylalanine derivatives as thrombin inhibitors |
| 03/04/1997 | US5607936 Useful in treatment of respiratory diseases |
| 03/04/1997 | US5607935 Treating stroke and cerebral ischemia |
| 03/04/1997 | US5607934 Preventing and treating diseases caused by superoxide radicals, nephritis |
| 03/04/1997 | US5607933 3-arylcarbonyl-1(C-attached-N-heteryl)-1H-indoles |
| 03/04/1997 | US5607932 Bactericides |
| 03/04/1997 | US5607931 1,2-disubstituted ethly amides as inhibitors of ACAT |
| 03/04/1997 | US5607930 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract |
| 03/04/1997 | US5607929 Antiviral dibenzothiazepinone derivatives |
| 03/04/1997 | US5607928 Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives |
| 03/04/1997 | US5607927 Cephalosporin derivative |
| 03/04/1997 | US5607926 Active against methicillin resistant bacteria |
| 03/04/1997 | US5607924 DNA photocleavage using texaphyrins |
| 03/04/1997 | US5607922 1,5-anhydrohexitol nucleoside analogues |
| 03/04/1997 | US5607921 Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof |
| 03/04/1997 | US5607699 Non-aqueous emiollient iodophor formulations |
| 03/04/1997 | US5607693 Cosmetic or pharmaceutical composition, especially dermatological composition, containing oxyacanthine, intended in particular for stimulating hair growth or retarding hair loss |
| 03/04/1997 | US5607690 Diclofenac, hydroxyethyl-pyrroldine or piperidine |
| 03/04/1997 | US5607685 Protracted-release adminstration forms containing clindamycin palmitate |
| 03/04/1997 | US5607671 Beta lactam antibiotics degrading compound |
| 03/04/1997 | US5607669 Amine polymer sequestrant and method of cholesterol depletion |
| 03/04/1997 | US5607662 Pharmaceutical inhalation compositions |
| 03/04/1997 | CA2166794C Magnesium omeprazole |
| 03/04/1997 | CA2077693C Use of ketorolac for treatment of periodontal disease |
| 03/02/1997 | CA2184570A1 Therapeutic agents for use in cancer therapy |
| 03/02/1997 | CA2184442A1 Process for the preparation of optically active ortho-substituted 4-aryl-dihydropyridines |
| 03/01/1997 | CA2184146A1 Heterocyclically substituted pseudopeptides |
| 03/01/1997 | CA2184145A1 Process for the preparation of medicament formulations with controlled release |
| 02/27/1997 | WO1997007404A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
| 02/27/1997 | WO1997007399A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
| 02/27/1997 | WO1997007233A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | WO1997007232A1 Antigenic preparations |
| 02/27/1997 | WO1997007218A1 Allergen-xcd32 fusion proteins |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007208A1 Nucleic acid molecules encoding peptides having pronociceptive properties |
| 02/27/1997 | WO1997007136A2 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 02/27/1997 | WO1997007134A1 Traf inhibitors |
| 02/27/1997 | WO1997007130A1 Novel opioid peptides |
| 02/27/1997 | WO1997007128A1 A method to increase the density of antigen on antigen presenting cells |
| 02/27/1997 | WO1997007125A1 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents |
| 02/27/1997 | WO1997007121A1 Purification process |
| 02/27/1997 | WO1997007120A1 Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists |
| 02/27/1997 | WO1997007118A1 Enediyne compounds |
| 02/27/1997 | WO1997007117A1 2-acylaminopropanamines as growth hormone secretagogues |
| 02/27/1997 | WO1997007116A1 Prolylendopeptidase inhibitors |
| 02/27/1997 | WO1997007115A1 Benzenesulphonamide derivatives as bradykinine antagonists |
| 02/27/1997 | WO1997007101A1 Radiation-activated cytotoxin therapy |
| 02/27/1997 | WO1997007098A1 (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate |
| 02/27/1997 | WO1997007097A1 Cyclopropylindoles and their seco precursors, and their use as prodrugs |
| 02/27/1997 | WO1997007093A1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 02/27/1997 | WO1997006833A1 Hyper comb-branched polymer conjugates |
| 02/27/1997 | WO1997006827A1 Control of cd44 gene expression for therapeutic use |
| 02/27/1997 | WO1997006826A1 Gene therapy using ovine adenoviral vectors |
| 02/27/1997 | WO1997006819A1 Compositions and methods for elmination of advanced glycosylation endproducts (in vivo) |
| 02/27/1997 | WO1997006818A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 02/27/1997 | WO1997006816A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 02/27/1997 | WO1997006814A1 Method of promoting angiogenesis |
| 02/27/1997 | WO1997006813A1 Mucosal preparation containing physiologically active peptide |
| 02/27/1997 | WO1997006811A1 Protection against pathogenic microorganisms |
| 02/27/1997 | WO1997006809A1 Compositions and methods for growth promotion |
| 02/27/1997 | WO1997006808A1 Combination osmotic and bulk forming laxatives |
| 02/27/1997 | WO1997006807A2 Contraceptive combined preparation, kits containing the same and contraceptive method using this combined preparation |
| 02/27/1997 | WO1997006806A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 02/27/1997 | WO1997006805A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies |
| 02/27/1997 | WO1997006804A1 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c |
| 02/27/1997 | WO1997006803A1 2-acylaminopropanamides as growth hormone secretagogues |
| 02/27/1997 | WO1997006802A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 02/27/1997 | WO1997006801A1 Composition containing mefenamic acid in association with codeine |
| 02/27/1997 | WO1997006800A1 Remedy for anxiety neurosis |
| 02/27/1997 | WO1997006799A1 Novel fused isoquinolines as dopamine receptor ligands |
| 02/27/1997 | WO1997006798A2 Pharmaceutical formulations |
| 02/27/1997 | WO1997006797A1 Endometrial ablation using photodynamic therapy with green porphyrins |
| 02/27/1997 | WO1997006796A1 Benzothiophene compounds |
| 02/27/1997 | WO1997006795A1 Pharmaceutical compositions containing gamma-butyrobetain for treatment of blood flow disorders |
| 02/27/1997 | WO1997006794A1 Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine |
| 02/27/1997 | WO1997006793A1 Non-steroidal sulfatase inhibitor compounds and their method of use |
| 02/27/1997 | WO1997006792A1 Potentiation of serotonin response |
| 02/27/1997 | WO1997006791A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS |
| 02/27/1997 | WO1997006790A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | WO1997006788A1 Transdermal administration of vorozole |
| 02/27/1997 | WO1997006786A1 Oral fast-dissolving compositions for dopamine agonists |
| 02/27/1997 | WO1997006783A1 Method and composition for treating asthma |
| 02/27/1997 | WO1997006770A2 Chitin extract for treatment of skin disease |
| 02/27/1997 | WO1997006769A2 Pharmaceutical composition with trypanocidal properties |
| 02/27/1997 | WO1997006662A2 Inverted chimeric and hybrid oligonucleotides |
| 02/27/1997 | WO1997004005A3 Cyclosporin derivatives with anti-hiv effect |
| 02/27/1997 | WO1997003082A3 Pyrimidine nucleoside derivatives |
| 02/27/1997 | WO1996022095A3 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 02/27/1997 | DE19531463A1 Pharmaceutical prepn. contg. bisoprolol and an alpha-1-receptor blocker |
| 02/27/1997 | DE19531342A1 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators |
| 02/27/1997 | DE19531067A1 Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität Use of boswellic acid and its derivatives for the inhibition of the normal and increased Leukozytenelastase- or plasmin |
| 02/27/1997 | DE19531014A1 Gelatin capsule contg. estragol oil and eugenol oil from basil |
| 02/27/1997 | DE19530996A1 Cyclische Guanidine, Verfahren zu ihrer Herstellung und Arzneimittel Cyclic guanidines, methods for their preparation and pharmaceutical |